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Designing novel possible kinase 
inhibitor derivatives as therapeutics 
against Mycobacterium 
tuberculosis: An in silico study
Mohd shahbaaz, Anati Nkaule & Alan Christoffels  
Rv2984 is one of the polyphosphate kinases present in Mycobacterium tuberculosis involved in the 
catalytic synthesis of inorganic polyphosphate, which plays an essential role in bacterial virulence 
and drug resistance. Consequently, the structure of Rv2984 was investigated and an 18 membered 
compound library was designed by altering the scaffolds of computationally identified inhibitors. The 
virtual screening of these altered inhibitors was performed against Rv2984 and the top three scoring 
inhibitors were selected, exhibiting the free energy of binding between 8.2–9 kcal mol−1 and inhibition 
constants in the range of 255–866 nM. These selected molecules showed relatively higher binding 
affinities against Rv2984 compared to the first line drugs Isoniazid and Rifampicin. Furthermore, the 
docked complexes were further analyzed in explicit water conditions using 100 ns Molecular Dynamics 
simulations. Through the assessment of obtained trajectories, the interactions between the protein 
and selected inhibitors including first line drugs were evaluated using MM/PBSA technique. The 
results validated the higher efficiency of the designed molecules compared to 1st line drugs with total 
interaction energies observed between −100 kJ mol−1 and −1000 kJ mol−1. This study will facilitate 
the process of drug designing against M. tuberculosis and can be used in the development of potential 
therapeutics against drug-resistant strains of bacteria.
In the past decades, protein kinases and G protein-coupled receptors have become the most significant group of 
drug targets for the pharmaceutical industry, with a large number of therapeutic molecules generated through 
protein kinase based drug optimization programs1,2. A majority of designed kinase inhibitors target the ATP 
binding site of the enzymes1–3. In bacteria, the kinases of two-component signal transduction systems involved in 
the protein phosphorylation are primary used as the drug targets3. In recent studies, the roles of bacterial protein 
kinases in virulence and in the sustainment of growth have been reported4. Therefore, bacterial protein kinases 
can be utilized as potential new drug targets5.
In pathogenic bacteria, Polyphosphate kinase - 1 (PPK1), an inner cell membrane-bound enzyme, reversibly 
catalyze the conversion of terminal inorganic phosphate (Pi) of ATP into the long-chain Polyphosphates6,7. This 
process involves the phosphorylation of histidine residue in the active site of PPK1, followed by the transforma-
tion of Pi into Inorganic Polyphosphate (Poly-P) by addition of ATP or back conversion to ATP by the addition 
of ADP6,7. Poly-P is a linear chain polymer of numerous inorganic phosphate residues linked together by phos-
phoanhydride bond6,7. The Poly-P is present ubiquitously in every living cell and plays a variety of physiological 
functions depending on the sub-cellular localization6,7. Poly-P is primarily involved in processes such as substi-
tution for ATP in kinase reactions, chelation of metals, reservoir of Pi, capsule of bacteria, buffer against alkali, 
mRNA processing, competence for bacterial transformation as well as play regulatory roles in a variety of stress 
conditions6,7. The experimental exposure to the stress conditions lead to the fluctuation in the intracellular level 
of Poly-P, and decreased concentration is coupled with impairment of various significant structural as well as 
cellular functionalities6,7. Furthermore, in addition to the synthesis of Poly-P, PPK1 also catalyzes the synthesis of 
nucleoside triphosphates from nucleoside diphosphates by utilizing the Poly-P as phosphate donor6,7.
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Besides PPK1, another widely conserved family of kinases involved in Poly-P metabolism is known as 
Polyphosphate kinase 2 (PPK2) enzyme6,7. The PPK2 family of enzymes contains a conserved P-loop motif for 
phosphate binding and is largely categorized into three subfamilies on the basis of substrate specificity (i.e. class 
I, II and III)6,7. The class I as well as class II PPK2 enzymes are involved in the phosphorylation of nucleoside 
diphosphate and nucleoside monophosphate, whereas, the class III PPK2 enzymes catalyzes the direct synthesis 
of nucleoside triphosphates from the nucleoside monophosphates6,7. However, the exopolyphosphatase (PPX) 
catalyzes the cleavage of phosphoanhydride bonds of Poly-P and enable the generation of inorganic phosphate6,7. 
The aforementioned enzymes are encoded in the genome of Mycobacterium tuberculosis and are involved in both 
Poly-P synthesis (Rv2984, PPK1) and its utilization (Rv3232c, PPK-2, and Rv0496, PPX). In vitro studies in the 
oxidative and antibiotic stress conditions revealed the accumulation of Poly-P in mycobacteria at a later stage of 
growth8. Furthermore, several studies revealed that the impaired survival of M. tuberculosis in macrophages is 
associated with dysregulation in Poly-P levels8.
In this study, a library of 18 inhibitors was designed by altering the scaffolds of computationally identified 
inhibitors using the concepts of combinatorial chemistry and the top three inhibitors were filtered using the vir-
tual screening against Rv2984. Furthermore, the generated docked complexes were further analyzed using 100 ns 
Molecular Dynamics (MD) simulations in explicit solvent conditions and their conformational behaviors were 
analyzed, which validated the outcomes of molecular docking. This combined in silico study provide significant 
structural insights into the inhibition of Rv2984 and may enable the identification of potential therapeutic agents 
against the infection of M. tuberculosis.
Results and Discussion
The past decades have seen a resurgence in the research of TB drug design and development, stimulated by an 
urgent need to curb the rise of the disease globally as well as to develop new, more effective therapies against 
drug-sensitive and resistant strains9. Consequently, there is now a variety of new products in clinical development 
and historically largest number of early-stage projects aimed at the development of pipelines regarding the formu-
lation of novel compounds were undertaken9. It is evident that the integration of the computational approaches 
with the experimental workflows can accelerate TB drug discovery10.
Previous studies used genome and metabolic pathway mapping to identify nine putative targets for the design 
of novel therapeutic agents11. In this study, Rv2984 was used as a target for the design of potential inhibitors 
against M. tuberculosis, because of its polyphosphate kinase 1 activity and experimentally confirmed role of this 
class of protein in virulence mechanisms of bacteria7. Accordingly, a library of 18 possible inhibitor molecules was 
designed (Table S1) using the principles of computational combinatorial chemistry12. The generated compounds 
were used to perform the virtual screening in the predicted binding sites of Rv2984 using GLIDE13,14. Therefore, 
the current study was undertaken to analyze the structural basis of inhibition using the top three scoring ligand 
molecules in the designed library.
Structure prediction and assessments. The conservation of Rv2984 was assessed in the genus myco-
bacteria using multiple sequence alignment performed by PRALINE15. Rv2984 showed very high similarity and 
conservation to the active site histidine residues His435 and His592 to the other mycobacterial polyphosphate 
kinases (PPKs) and the consensus protein sequence was derived from the alignment (Fig. S1). Consequently, the 
homology modelling algorithm implemented in “PRIME” was used for the prediction of the Rv2984 structure. 
BLASTP was used to identify a reliable template in the biological database. Rv2984 showed similarities with the 
crystal structure of polyphosphate kinases of Escherichia coli (PDB ID - IXDO, 34% identity) and Porphyromonas 
Gingivalis (PDB ID - 2O8R, 35% identity). These two templates were selected for building the homology models 
by satisfying the spatial restraints. The predicted structures were subjected to energy minimization and their 
loops were further refined using the structure optimization modules present in the Schrödinger software suite. 
Moreover, the structure of Rv2984 was further refined using 10 ns MD simulations. The model was subjected to 
subsequent minimization, equilibration and production stages using GROMACS simulation package16 in explicit 
water conditions. The quality of the predicted structure was evaluated using ProQ17 and ProSA-web18 servers. 
The ProQ assessed the quality of the predicted model on the basis of LGscore and MaxSub scores, which were 
calculated to be around 5.565 and 0.534 respectively, classifying the model in extremely good prediction category. 
Similarly, the ProSA-web calculated the overall quality of Rv2984 model in the form of Z-score of −11.62 indicat-
ing the reliable prediction of the 3-D structure. In addition, the 3-D model showed 95.9% of the residues in the 
allowed region of the Ramachandran plots, demonstrating the stereochemical reliability of the predicted models.
The structural comparison of the predicted Rv2984 structure showed the presence of L-shaped topology with 
25 α-helices and 19 β-strands, organized into four structural domains (Fig. 1). After comparison with the tem-
plate, these four domains were classified as the N-terminal domain, the ‘head’ domain as well as two closely 
related C-terminal domains19. The N-terminal domain, from residues 1–155, comprises three anti-parallel hel-
ices (α1–α3). In bacterial PPKs, the N-terminal domain is highly conserved which provides an upper binding 
interface for the adenine ring of the ATP19. The Head domain (Residues 156–375), showed a core α/β/α fold 
in the middle of the Rv2984 topology and may be involved in the dimerization19. The C1 (Residues 376–556) 
and C2 (557–742) terminal domains contain mixed β-sheet flanked by α-helices. These C-terminal domains are 
highly conserved and may be associated with the catalytic activity19. Afterwards, the pharmacophore models 
were generated using PHASE pharmacophore generator present in Schrödinger software suite20. Receptor-ligand 
common feature pharmacophoremodels were generated and the drugs bearing the same features were searched 
in the available databases. Consequently, the 18 compound derivatives were designed using combinatorial 
approaches (Table S1). The drug-likeness of the designed molecules were assessed using “Ligand-based ADME/
Tox Prediction” Module and validated using vNN server for ADMET Predictions21. The molecules showed the 
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presence of no cytotoxicity, low metabolism in the liver, no cardiotoxicity, no mitochondrial toxicity as well as no 
mutagenicity. Therefore, these molecules were selected for further study.
Docking-based interaction studies. The analyses of the active site of template PPK (PDB ID – IXDO) 
showed that His435 and His592 function as the autophosphorylation sites19. After structural analyses, the corre-
sponding autophosphorylation sites were located in the residues His491 and His652 of predicted Rv2984 struc-
ture. The Histidine residue is highly conserved in the core active sites of kinases and usually forms the part 
of the structural motifs such as His-x-Asp22. The replacement of these His residues in His-x-Asp motifs with 
Phenylalanine or Arginine leads to the impairment in the catalytic as well as autophosphorylation activity22. 
The probable active site pockets were predicted using the AutoLigand module of the AutoDock software suite23. 
The hotspot sites for the drug designing were further validated in the structure of Rv2984 using Fpocket24 and 
3DLigandSite25 servers, which identified 72 ligand binding sites and recognizes the ATP in the binding site. The 
pocket 1 (Depicted in Fig. 1) was selected for the virtual screening. Subsequently, the designed derivative mole-
cules were docked in the predicted active site of Rv2984. The abbreviated names of the used derivatives were listed 
in Table S1.
The docked pose 36 was selected for the complex Rv2984_HEN (Table 1) and it was observed that HEN 
was interacting with Ser90, Arg431, Asp463, His491, Tyr524, Arg624, and Ile626 (Fig. 2A). The HEN derivative 
showed the highest value of the inhibition constant of 866.29 nM along with the free energy of binding calculated 
to be around −8.27 kcal mol−1 (Table 1). Similarly, the TET was found to be interacting with Arg99, Arg431, 
Arg461, Asp463, His491, Asn515, Asn517, Tyr524, His652, and Arg679 (Fig. 2B) in the selected docked pose 30. 
In complex Rv2984_TET, the least value of inhibition constant of 255.33 nM was calculated, while it showed the 
highest free energy of binding of −8.99 kcal mol−1 (Table 1). Furthermore, in Rv2984_OXO complex, the pose 2 
was selected and the residues Trp60, Asn91, Arg99, Arg431, Arg461, Phe462, Lys489, His491, Lys519, Arg624, 
His652, and Arg679 were found to be interacting with OXO (Fig. 2C). The respective complex showed the combi-
nation of the free energy of binding and inhibition constant to be around −8.56 kcal mol−1 and 528.83 nM respec-
tively. Both the potential autophosphorylation sites i.e. His491 and His652 are observed in the Rv2984_TET 
and Rv2984_OXO complexes, while only His491 was observed in Rv2984_HEN (Fig. 2), indicating the binding 
efficiency of TET and OXO derivatives with Rv2984.
Experimental studies have identified that the PPK is associated with the reduction of first-line drugs suscepti-
bility as well as required for intracellular survival of M. tuberculosis in macrophages8,26,27. Therefore, the first line 
drugs such as Rifampicin (RIF) and Isoniazid (ISO) was docked in the active pocket of Rv2984 and their binding 
Figure 1. The predicted structure of Rv2984 showing characteristic L-shaped topology organized in 25 
α-helices and 19 β-strands. (Spheres depict the predicted binding pocket).
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affinities were compared with the designed derivatives. In Rv2984_ISO complex, the free energy of binding of 
−4.64 kcal mol−1 and inhibition constant of 393.73 nM was observed (Table 1). The selected 19th docked pose 
of Rv2984_ISO complex showed interaction with Leu523, Tyr524, Lys596, Arg624, Ile645, Leu650, Glu651, and 
His652 (Fig. 3A). Similarly, in Rv2984_RIF complex the drug showed the free energy of binding and inhibition 
constant of −9.74 kcal mol−1 and 72.83 nM respectively, with Phe462, Asp463, Asn515, Asn517, Thr529, His652, 
and Tyr524 were observed in interaction pocket (Fig. 3B). In first line drug complexes, only His652 was observed 
in the interaction site, but the structural comparison with template showed that the primary autophosphorylation 
sites may be located at His491.
Therefore, the designed inhibitor derivates probably target the autophosphorylation sites in the Rv2984 with 
comparable efficiency in comparison with the first line drugs. These generated parameters showed that designed 
derivatives are favorably binding in the active sites of Rv2984 and can be used to inhibit the function of the pro-
tein. These observations emphasized the suitability of these designed inhibitors to be used as potential therapeu-
tics against M. tuberculosis. Furthermore, in order to obtain deeper insight into the generated complexes, each of 
them was subjected to 100 ns MD simulations in explicit water conditions and correlation of these observations 




















1. Rv2984_HEN(RMS = 1.42) 36 −8.27 866.29 −0.15 −12.02 −11.85 −3.02 3.58
2. Rv2984_TET(RMS = 0.2) 30 −8.99 255.33 −0.21 −8.33 −11.38 −5.79 2.39
3. Rv2984_OXO(RMS = 0) 2 −8.56 528.83 −0.17 −10.47 −13.34 −4.43 4.77
4. Rv2984_ISO(RMS = 0.64) 19 −4.64 393.73 −0.46 −4.87 −5.24 −0.51 0.6
5. Rv2984_RIF(RMS = 0.74) 33 −9.74 72.83 −0.17 −11.36 −11.53 −0.19 1.79
Table 1. List of generated docking scores and parameters for Rv2984.
Figure 2. The energy minimized conformations showing (A) The 36th docked pose for the Rv2984_HEN 
complex, (B) Selected 30th pose of complex Rv2984_TET, and (C) The generated stable pose of the Rv2984_
OXO complex.
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Changes in molecular dynamics patterns. In addition to the molecular docking studies, the Molecular 
Dynamics (MD) simulations were used to obtain a deeper insight into the structural changes observed during 
the course of inhibition. The MD simulations were widely used in the process of structure-based drug designing, 
for generating the structural conformer of the receptor crystal structure before docking as well as for predicting 
the most energetically minimized binding modes of the top ranking lead compounds as a final filter for guiding 
the chemical synthesis for hit optimization28. Consequently, all the generated docked complexes were immersed 
in the SPC/E water model and then subjected to the process of minimization for 1000 steps of steepest descent, 
followed by equilibration and finally subjected to 100 ns MD simulations. The trajectories generated for each 
complex were analyzed using the utilities present in GROMACS and the obtained outcomes were discussed in the 
following sections of the article.
Variations in bonding patterns demonstrate that the combinatorial designed inhibitors bind more tightly than the 1st 
line anti-TB drugs. The gmx_mpi pairdist module was used to calculate the distance between the structure of 
Rv2984 and the ligand molecules during the course of simulations. The average distance for the complex Rv2984_
HEN was observed to be around 0.19 nm (Fig. 4A); while for the complexes Rv2984_TET and Rv2984_OXO it 
was computed to be around 0.17 nm and 0.18 respectively (Fig. 4B,C). Likewise, an average distance of 0.21 nm 
was observed for the complex Rv2984_ISO as well as for the Rv2984_RIF average value of 0.20 nm was computed 
(Fig. 4D,E).
Furthermore, the bonding patterns were further assessed by observing the fluctuations of the hydrogen 
bonds in the studied complexes (Fig. 5). Around seven hydrogen bonds were observed in complex Rv2984_HEN 
(Fig. 5A), while in complexes Rv2984_TET and Rv2984_OXO around 10 and 12 hydrogen bonds were computed 
respectively (Fig. 5B,C). Similarly, around six hydrogen bonds were calculated for the complex Rv2984_ISO and 
eight for Rv2984_RIF (Fig. 5D,E). These observations indicated that the OXO showed highest bonding parame-
ters followed by TET and HEN, which were binding more tightly than the first line drugs.
Assessment of structural compactness. The Radius of gyration (Rg) is a parameter used to evaluate the stabil-
ity of the complexed biological systems along the MD trajectories by calculating the structural compactness of 
the biomolecules. The average Rg values for complexes Rv2984_HEN and Rv2984_TET were calculated to be 
around 2.54 nm and 2.58 nm respectively, in which the systems become relatively stable as the MD simulations 
approach towards 100 ns time scale (Fig. 6A,B). While for complex Rv2984_OXO highest number of fluctuations 
was observed throughout the course of simulations with average Rg value of 2.70 nm (Fig. 6C). Furthermore, the 
average Rg value for complexes Rv2984_ISO and Rv2984_RIF was computed to be around 2.68 nm and 2.63 nm 
respectively, with lesser fluctuation during 100 ns MD simulations (Fig. 6D,E). These findings indicated that the 
highest structural compactness was observed in the complexes Rv2984_HEN and Rv2984_TET, while higher 
fluctuations were observed in Rv2984_OXO which attributed to the active interaction of Rv2984 with the ligand. 
Furthermore, in comparison with free protein structure, the relatively similar behavior of compactness was 
observed for each complex (Fig. 6).
Figure 3. Docking results of 1st line drugs. (A) The selected conformational pose of Rv2984_ISO docked 
complex illustrating the interacting residues and (B) The energetically stabilized complex of first-line drug RIF.
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Deviations in conformational elements. The evaluations of structural similarities are considered as a crucial 
method for the prediction of protein functions as well as their folding in 3-D space. Therefore, the differences in 
the conformations of the structural elements were compared in order to obtain the stability profiles of the studied 
complexes. The Root Mean Square Deviation (RMSD) is a parameter aimed at the calculation of the deviations in 
the conformational stability of macromolecules from the backbone structure to the initial starting structure. The 
complexes Rv2984_HEN and Rv2984_TET showed a similar pattern of RMSD values fluctuations, with average 
RMSD values of 0.71 nm and 0.70 nm respectively (Fig. 7A,B). While for complex Rv2984_OXO, the average value 
was calculated to be around 0.53 nm with fluctuation observed in the range of 0.4–0.6 nm (Fig. 7C). This indicated 
that the complex Rv2984_OXO is relatively stable in comparison to the other designed derivatives’ complexes. In 
comparison with the complexes of the first line drugs, the Rv2984_ISO showed the average value of 0.61 nm with 
Figure 4. The graphical illustration of changes observed in the distances between Rv2984 and the complexed 
ligand molecules (A–E) during the course of 100 ns MD simulations.
Figure 5. The 2-D diagram describing the dynamics observed in the hydrogen bonding patterns for the studied 
Rv2984 complexes (A–E) for the time scale of 100 ns.
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relatively higher perturbations indicating the unstable nature of the complex (Fig. 7D). Similarly, the Rv2984_RIF 
showed 0.62 nm as the average RMSD value with the inclined fluctuation pattern (Fig. 7E). These observations 
indicated that the Rv2984_OXO showed a relatively stable RMSD profile in comparison to the other complexes, 
while free proteins showed little changes in the RMSD values while compared with the complexed form (Fig. 7).
Fluctuations in the residual components. The variations in the constituent residues of Rv2984 were observed for 
each complex and were plotted as a function of time during the course of 100 ns MD simulations (Fig. 8). The 
His491 and His652 form the part of loop regions adjacent to β12 and β17 (Fig. 1). In complex Rv2984_HEN, 
the His491 and His652 showed Root Mean Square Fluctuations (RMSF) of 0.151 nm and 0.136 nm respectively 
(Fig. 8A). The complex Rv2984_TET showed relative active interactions with the residues as indicated by the 
Figure 6. Radius of Gyration plots highlighting the changes observed in the conformational behavior of the 
studied docked complexes (A–E) during 100 ns MD simulations. (The changes in the Rg values for the free 
protein is depicted in orange color).
Figure 7. The curves illustrating the changes in the RMSD values for each studied complex (A–E) during 100 ns 
MD simulations. (The changes in the RMS values for the free protein is depicted in orange color).
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RMSF values of 0.192 nm and 0.114 nm (Fig. 8B). While in complex Rv2984_OXO the least RMSF values of 
0.152 nm and 0.101 nm were observed for the respective residues (Fig. 8C). Furthermore, in complex Rv2984_
ISO the residues showed active interaction with the first line drug isoniazid which can be indicated from the 
RMSF values of 0.207 nm and 0.125 nm (Fig. 8D). Moreover, in Rv2984_RIF the residues showed RMSF values 
of 0.182 nm and 0.128 nm, which slightly lesser as compared to isoniazid complex (Fig. 8E). These plotted data 
showed that the complexes of designed derivatives showed active interaction with His491 and His652 and com-
parable RMSF values with 1st line TB drugs.
Alterations in solvent accessibility. The Solvent Accessible Surface Area (SASA) is a parameter computed using 
gmx_mpi sasa module of GROMACS, which measures the proportion of the biomolecules surface interacting 
with the water solvent. The calculation of SASA can be used for predicting the extent of the conformational 
changes occurred during the course of binding29. The average SASA of 281.97 nm2 was calculated for Rv2984_
HEN, while for Rv2984_TET and Rv2984_OXO complexes it was found to be around 286.63 nm2 and 297.22 nm2 
respectively (Fig. 8A–C). Likewise, the Rv2984_ISO and Rv2984_RIF showed the average value of SASA to 
be around 297.25 nm2 and 293.87 nm2 (Fig. 9D,E). These calculations showed that the Rv2984_HEN was least 
exposed to the water solvent during 100 ns MD simulations followed by Rv2984_TET, indicated the relatively 
stable nature of these complexes as compared to the rest of the studied systems.
Dynamics of interaction energies. In order to validate the binding energy parameters generated using molecular 
docking studies, a detailed analysis was performed regarding the calculation of the free energies of interaction 
associated with the binding of ligand molecules with the structure of Rv2984 using MM–PBSA method imple-
mented in GROMACS. The total binding energies of all the designed derivative molecules and Rv2984 were 
observed in the range of −1000–1500 kJ mol−1 (Fig. 10A–C). While for the complexes generated using first-line 
drugs the total energy was calculated to be around −200 kJ mol−1 (Fig. 10D,E). These interaction energy calcu-
lations validated the molecular docking results, showing that the designed derivative molecules were favorably 
binding to the Rv2984 and can use as potential drug molecules.
Methods
Molecular modelling. Due to the unavailability of Three Dimensional (3-D) structures for Rv2984 (UniProt 
ID - P9WHV9) in biological databases, its structure was predicted using “PRIME” homology modelling mod-
ule of Schrödinger30,31. The generated 3-D structures of Rv2984 were subjected to further optimization which 
includes minimization, side chain as well as loop refinement. The structures of designed ligands were constructed 
by means of drawing utilities present in the MAESTRO (Schrödinger Release 2018-1: Maestro, Schrödinger, LLC, 
New York, NY, 2018) and the geometries of the resulted ligand structures were optimized by using the Density 
Functional Theory (DFT) method present in JAGUAR32.
Molecular docking studies. The obtained structures generated ligands were docked in the potential bind-
ing sites of Rv2984 by using AutoDock 433 package. This software performs the prediction of the bound confor-
mation based on the free energy, which was calculated on the basis of the empirical force field and the Lamarckian 
Genetic Algorithm33. The AutoGrid module was used to create a grid box of dimensions 50 × 54 × 46 Å along the 
Figure 8. The graphs highlighting the changes observed in the fluctuations of the constituent residues involved 
in the interaction of the Rv2984 with the ligand molecules in the studied complexed systems (A–E).
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XYZ directions with a spacing of 0.375 Å. The efficiency of the predictions was amplified by setting the parame-
ters associated with the Lamarckian genetic algorithm to the maximum efficiency values. This was achieved by 
setting number of individuals in population to 250 and the maximum number of energy evaluations to a “longer” 
interval. The 100 docked conformations were generated for each Rv2984 and ligand systems which were further 
Figure 9. The SASA curves showing the variation in the solvent accessibility of the studied complexes (A–E) 
during the course of 100 ns MD simulations.
Figure 10. The MM-PBSA analysis of docked complexes based resulted curves (A–E) showing the behavior of 
the interactions in the form of free energies of binding between the Rv2984 and ligand molecules.
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grouped according to the RMSD tolerance of 2.0 Å. The free energy of binding was used as a parameter for assess-





























































here, ΔGvdW symbolizes the van der Waals, ΔGHbond represents Hydrogen Bonding while ΔGelec and ΔGsol stand 
for the free energy of Electrostatics and solvation, respectively.
The re-scoring of the generated conformations were performed on the basis of the scoring function pres-
ent in DrugScoreX server34 and the docked conformation with the highest score was selected for the Molecular 
Dynamics (MD) simulations. The generated outcomes were validated using the Glide docking module imple-
mented in Schrödinger13.
Molecular dynamics (MD) simulations. The obtained docked complexes were subjected to MD sim-
ulations using GROMACS 5.1.216,35 and the topologies of the complexed structures were generated using 
GROMOS96 53a6 force field36. The GROMACS package lack an appropriate force field parameters for drug-like 
molecules, therefore, the PRODRG server37 was used for the generation of topologies and coordinate files of 
the ligand molecules. Furthermore, the partial charges in the generated topologies were corrected using DFT 
method implemented in GAUSSIAN38 which utilized the B3LYP 6–31 G (d,p) basis set and the CHELPG pro-
gram39. Afterward, all the docked complexes were solvated in SPC/E water model40 as well as the neutralization 
was performed by adding the counter ions. Consequently, the neutralized systems were energetically minimized 
by steepest descent and conjugate gradient algorithms with a convergence criterion of 0.005 kcal/mol and the 
restraints were applied to the structure of the ligands before the equilibration phase.
The equilibration step was performed in NVT (constant volume) as well as NPT (constant pressure) ensemble 
conditions, each with a 100 ps time scale. The temperature of the system was maintained at 300 K using Berendsen 
weak coupling method in both ensemble conditions as well as the pressure, which was maintained at 1 bar by 
utilizing Parrinello-Rahman barostat in constant pressure ensemble. The final MD simulations were produced 
using LINCS algorithm for 100 ns time scale. The generated trajectories were used to analyze the behavior of 
each complex in the explicit water environment. The deviations in the distances, H-bonds, RMSD (Root Mean 
Square Deviations), and Radius of Gyration (Rg) were analyzed between the complexed protein and ligand. 
Furthermore, the free energy of binding was calculated using Molecular mechanics Poisson–Boltzmann surface 
area (MM-PBSA) protocols implemented in the g_mmpbsa package41 which provide deeper insights into the 
interaction mechanisms of the proteins and the ligand molecules.
Conclusions
This study involves the design of novel inhibitor molecules against the Rv2984 protein which functions as 
polyphosphate kinase in Mycobacterium tuberculosis. Consequently, a library of 18 derivative molecules was 
designed using a variety of in silico techniques. The interaction patterns of the selected designed molecules were 
analyzed using molecular docking techniques and the generated parameters were compared with that obtained 
for the first line drugs demonstrates that the designed molecules bind more efficiently to Rv2984. These detailed 
computational analyses provide deeper structural insight into the interacting residues of Rv2984 involved in the 
process of inhibition. Furthermore, the MD simulation studies were used in order to understand the conforma-
tional behaviors of the studied Rv2984 complexes with the ligand molecules. The outcomes of MM-PBSA tech-
nique validated the molecular docking studies and showed that the designed derivative molecules were binding 
efficiently to the structure of Rv2984. These detailed analyses indicated that the binding properties of the designed 
molecules are comparable to the first line drugs and can be utilized as potential therapeutic agents against M. 
tuberculosis infection.
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